BioMarin Pharmaceutical (Nasdaq: BMRN) develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Recent Mentions on Fool.com
- BioMarin Pharmaceutical, Inc.: Is This Orphan Drug Specialist Overvalued?
- BioMarin Pharmaceutical Inc: The Future Looks Bright
- What You Need to Know About BioMarin's Vimizim Ahead of the FDA Decision
- The 3 Most Ridiculous Biotech Buyout Rumors Over the Past Year
- This Week in Biotech: Clinical Success, Plus Wheeling and Dealing